Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Intraosseous infusion devices Market Set To Climb From $3.61 Billion In 2026 To $4.71 Billion By 2030
The intraosseous infusion devices market has experienced significant expansion recently. This market is projected to expand from $3.39 billion in 2025 to $3.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. Historically, this growth was primarily driven by factors such as a rise in trauma and cardiac emergencies, the necessity for swift vascular access in hospital settings, the uptake of manual IO devices, the expansion of emergency medical services (EMS), and the early application of intraosseous needles in pediatric care.
The intraosseous infusion devices market size is projected for substantial expansion in the coming years. It is set to reach $4.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This growth throughout the forecast period is primarily fueled by the increasing uptake of automated IO devices, the incorporation of IO systems into hospital emergency procedures, the broader application of IO in ambulatory surgical centers, enhanced investment in training and simulation resources, and the creation of multi-site intraosseous access options. Noteworthy trends anticipated during this period encompass expedited emergency vascular access, adaptations for both pediatric and adult devices, the emergence of battery-powered and reusable drivers, the widespread embracing of single-use and disposable devices, and the deeper integration of training and simulation.
Get A Free Sample Report With In-Depth Market Insights:
Intraosseous infusion devices Market Growth Momentum: What Factors Are Shaping Demand?
The intraosseous infusion devices market is projected to expand due to the increasing frequency of trauma and emergency medical situations. These situations encompass urgent medical needs arising from severe injuries, acute illnesses, or critical conditions demanding immediate assessment and intervention. The rise in such cases is largely attributable to an uptick in road traffic accidents, intensified by greater vehicle density and higher travel speeds, leading to more serious injuries and subsequent emergency hospitalizations. Intraosseous infusion devices are crucial in these scenarios, offering quick and reliable access to the bloodstream when conventional intravenous access is challenging, especially in trauma or shock cases. This ensures the prompt delivery of fluids and vital medications, thereby facilitating timely and effective emergency care. For instance, as reported by the National Health Service, a UK government health agency, in September 2025, total accident and emergency attendances reached 27.4 million in 2024–25, marking a 4.0 percent increase compared with 2023–24. Consequently, the rising prevalence of trauma and emergency cases is a key factor propelling the growth of the intraosseous infusion devices market. The Rising Hospital Admissions Driving The Growth Of The Market Due To Increasing Critical Care Needs
Intraosseous infusion devices Market Segment Landscape: Which Areas Lead Development?
The intraosseous infusion devices market covered in this report is segmented –
1) By Product: Bone Injection Gun (B.I.G), First Access For Shock And Trauma 1 (FAST1), Easy Intraosseous (EZ-IO), First Access For Shock And Trauma Responder (FASTR), Intraosseous (IO) Needles, Other Products
2) By Technology: Manual, Automatic
3) By Route Of Administration: Sternum, Distal And Proximal Tibia, Distal Femur, Calcaneus, Head Of Humerus
4) By End User: Emergency Medical Services (EMS), Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers
Subsegments:
1) By Bone Injection Gun (B.I.G): Manual Activation, Spring Loaded Mechanism, Single Use Device, Adult Use Variant
2) By First Access For Shock And Trauma 1 (FAST1): Sternal Access Device, Single Use System, Rapid Vascular Access, Emergency Use Configuration
3) By Easy Intraosseous (EZ-IO): Battery Powered Device, Multiple Needle Sizes, Reusable Driver System, Emergency And Hospital Use
4) By First Access For Shock And Trauma Responder (FASTR): Sternal Insertion System, Prehospital Emergency Use, Single Use Configuration, Rapid Deployment Design
5) By Intraosseous (IO) Needles: Manual Insertion Needles, Powered Insertion Compatible, Pediatric Size Needles, Adult Size Needles
6) By Other Products: Disposable Intraosseous Devices, Training And Simulation Devices, Accessory And Stabilization Kits, Custom Intraosseous Systems
Intraosseous infusion devices Market Trends Redefining Industry Growth
Leading companies engaged in the intraosseous infusion devices market are concentrating on developing advanced systems, such as rapid vascular access devices, to facilitate quicker and more dependable vascular access during life-threatening emergencies. A rapid vascular access device serves as a medical tool that enables fast entry into the circulatory system for the administration of fluids, medications, or blood products in emergency and critical care scenarios. It is particularly employed when traditional intravenous access is difficult, time-consuming, or impractical. For example, in October 2024, BD, a US-based medical technology company, introduced the new BD Intraosseous Vascular Access System, an enhanced intraosseous access system built to establish vascular access within seconds for critical care situations. This system incorporates improved needle control, rapid insertion capability, and a user-friendly design to assist clinicians in high-pressure environments, consequently enhancing procedural efficiency and improving patient outcomes in emergency and acute care settings.
Intraosseous infusion devices Market Leading Companies And Competitive Benchmarking
Major companies operating in the intraosseous infusion devices market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company (BD), B Braun Melsungen AG, ZOLL Medical Corporation, Teleflex Incorporated, Cook Medical LLC, Shandong Weigao Group Co Ltd, Vygon SA, Argon Medical Devices Inc., Life Assist, Istem Medikal, SAM Medical Products, Implox Pty Ltd., BIOPSYBELL S R L (BPB Medica), Medax SRL, Troge Medical GmbH, Taizhou Kindly Medical Devices Co Ltd, PAVmed Inc., and Pyng Medical Corporation
View The Full Intraosseous infusion devices Market Report:
Intraosseous infusion devices Market Top Region By Revenue And Market Share
North America was the largest region in the intraosseous infusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraosseous infusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model